No Data
No Data
BCAL Diagnostics Shares Resume Trading After Equity Raising Announcement
BCAL Diagnostics Appoints CEO
BCAL Diagnostics Joins Forces to Conduct Breast Cancer Blood Test Study in India
BCAL Diagnostics Secures AU$3 Million R&D Tax Rebate for Fiscal Year 2023; Shares Fall 5%
BCAL Diagnostics Files for Additional Australian Patent Application
Blood Screening Market Size to Grow by USD 1.17 Billion From 2022-2027| Apollo Hospitals Enterprise Ltd., Aster Clinical Lab LLP, BCAL Diagnostics Ltd., and More Among the Major Companies in the Market - Technavio
No Data